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THE responsiveness of 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced
mammary tumours to hormonal manipulation has received much attention in
recent years, largely because the hormone dependency ofthese neoplasms resembles
that of certain human breast cancers, and evaluation of the response of these
tumours to changes in hormonal environment might have useful clinical applica-
tions (Huggins, Grand and Brillantes, 1961; Sterental, Dominguez, Weissman and
Pearson, 1963; Teller, Stock, Stohr, Merker, Kaufman, Escher and Bowie, 1966).
Relatively little emphasis has been placed on the role of endogeneous or exo-
genous progesterone in the genesis of mammary cancer. The few published
reports have dealt mainly with the effects of pregnancy or pseudopregnancy or of
exogenous progesterone on mammary tumour induction in rats or mice by DMBA
or 3-methylcholanthrene (3MCA) (Dao and Sunderland, 1959; Dao, Greiner and
Sunderland, 1959; Huggins, Briziarelli and Sutton, 1959; Howell, 1960; Huggins
et al., 1961; Biancifiori and Caschera, 1962; Huggins, Moon and Morii, 1962;
Marchant, 1963; Gruenstein, Shay and Shimkin, 1964; McCormick and Moon,
1965; Poel, 1965). In most ofthese experiments the investigators concluded that
progesterone or progestational states enhanced mammary carcinogenesis, although
there is no agreement as to the extent of this enhancement even within the same
strain of animal. Huggins et al. (1962) induced pregnancy in Sprague-Dawley
rats 15 days after administering DMBA, and found that the time for tumour
induction was shortened and the ilumber of tumours per rat was increased in
comparison with virgin control rats which received only DMBA. McCormick and
Moon (1965) extended this experiment to observe the effects ofinducing pregnancy
not only before tumour development, but also after the first tumours had appeared.
They confirmed the findings of Huggins and co-workers, and also found that the
tumour growth rate was increased whether pregnancy were induced before or after
theneoplasms had appeared. Whenpregnancy wasinduced afterthefirst tumours
had developed, they noted that further new growths arose. Huggins et al. (1962)
also investigated the effects of exogenous progesterone on DMBA-induced mam-
mary tumours in Sprague-Dawley rats, by injecting 4 mg. of progesterone daily
for 30 days beginning 15 days after DMBA administration. They found that, like
pregnancy, it enhanced mammary carcinogenesis.
The present experiments were designed with three objectives: to confirm the
findings of Huggins and co-workers of the effects of administering exogenous
progesterone to Sprague-Dawley rats 15 days after DMBA administration; to
determine the effects of giving progesterone two days before DMBA administra-
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tion; and to find out if, when progesterone was administered after the first DMBA-
induced tumours haddeveloped, similarresults would be obtainedtothosereported
by McCormick and Moon (1965) following the induction of pregnancy in tumour-
bearing rats.
MATERIALS AND METHODS
One hundred and five non-inbred Sprague-Dawley virgin female rats, descen-
ded from stock imported from Maidon, Wisconsin, and bred commercially in
Great Britain, were divided into five groups (Table I), housed five rats per cage,
TABLE I.-Treatments Used and the Resulting Incidences and Average Latent
Periods for Mammary Tumour Development, Percentage of Animals with
Multiple Mammary Tumours and Average Number ofActive Centres per Rat
Average No.
Average of active
latent Percentages centres
No. of Average Percentage period in of rats with per rat
rats progest- of rats days for multiple* of those
surviving erone in developing appearance mammary tumours with
longer mg. absorbed mammary of first of those devel- multiple*
Group than per rat tumours in mammary oping mammary mammary
No. Treatment 4 weeks per 30 days 28 weeks tumour growths tumours
I DMBA 21/22 - 430 113 37-0 2-0
2 DMBA+P o 21/23 87 1 70-0 5*1
3 DMBA + P + 15 19/20 90 84-0 94 88-0 4.9
4 DMBA + P-2 14/20 89 64-0 69 78-0 3.9
5 P-2 17/20 92 0.0 -
* Two or more tumours per rat
and fed commercial rat pellets, supplemented with greens occasionally, milk twice
a week and water ad libitum. At 50 days of age each rat in groups of 1-4 was fed
intragastrically a single 30 mg. dose of DMBA dissolved in 2 ml. of corn oil. In
addition, groups 2-4receivedprogesterone implants. Ingroup 2 (DMBA + P oo),
only rats bearing measurable mammary tumours (1 cm. or more in longest dia-
meter) were given progesterone, while in group 3 (DMBA + P + 15) and group 4
(DMBA + P - 2) all rats received progesterone, beginning on the 65th and 48th
day of age, respectively. Rats in control group 5 (P - 2) received progesterone
only, beginning on the 48th day of age. The circular hormone implants (1 cm. in
diameter) were made by compressing approximately 200 mg. of progesterone
powder under 5-6 tons pressure. Each pellet was accurately weighed and
implanted intraperitoneally for 30 days. The pellets were removed every 30 days
and new pellets implanted; this procedure was continued for the duration of the
experiments (61 months). The fibrous capsule was stripped off each pellet after
removal, the progesterone allowed to dry and then reweighed to ascertain the
amount absorbed per rat per 30 days.
Beginning 4 weeks after DMBA administration, all rats were palpated weekly
and the presence of any mammary tumours recorded. When the neoplasms
reached 1 cm. or more in longest diameter, they were measured with callipers in
two diameters, one in the longest axis ofthe growth and the other atright angles to
it. The arithmetical mean ofthese two measurements was used as the measure of
tumour size, and this value was graphed so that the growth progress of each neo-
plasm could be followed.
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Portions of each tumour removed at biopsy or autopsy were fixed in 10%
buffered formalin and embedded in paraffin. Sections were cut at 5 u and stained
with haematoxylin and eosin and alcian blue. Frozen sections were also cut from
some tumours and stained for fat by Sudan III.
RESULTS
Within the first 4 weeks ofthe experiments one or more rats died in each ofthe
five groups from one of several causes, including suppurative bronchopneumonia,
ether anaesthesia overdose, or the toxic effects of DMBA, most deaths occurring
in group 4 (Table I). As no mammary tumour was observed to develop during
this period, all figures and statistics have been based on the total number of rats
which survived longer than four weeks.
TABLE II.-Average Number of Active Centres per Rat in Each Group
and its Standard Deviation
Average No.
of active Standard
Total No. centres error of
Group No. of rats
1 21 0 0 52 . 0K16
2 . 21 1*86 . 0*63
3 19 . 3.74 . 0*67
4 14 . 2-07 . 0-78
Weighted
average
3&;4 . 33 . 303 . 050
Weighted
average
2, 3&4 . 54 . 2-57 . 039
* Standard errors quoted are based on the original figures, but since these figures gave variance
estimates which indicated heterogeneity, the data were transformed in such a manner as to reduce the
heterogeneity before any comparisons were made.
Tumour incidence
The average amount of progresterone absorbed per rat per 30 days in groups
2-5was similar (Table I), and byinspection the slight difference wasnot significant.
However, while mammary neoplasia did not arise in any animal of group 5,
which received only progesterone, breast tumours developed in some rats in each of
the other groups (1-4). Further, the tumour incidence was considerably increased
in those animals which had received progesterone either just before, or 15 days
after, DMBA administration (groups 3 and 4), compared with the combined
average incidence in those which had received only DMBA (groups 1 and 2),
(Table I). The tumour incidences in the latter two groups were combined and
averaged, sinceprogesterone was notadministered to anyrat ingroup 2 untilithad
developed a growth ofmeasurable size (1 cm. or more in longest diameter).
An overall x2 test on the observed numbers of rats developing tumours in
groups 1-4 indicated that progesterone significantly modified the effect ofDMBA
(X2 =9-8 for 3 d.f.). There was nosignificant difference in the incidence in groups
1 and 2, nor did group 3 differ significantly from group 4; however the combined
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inicidence rate in groups 3 and 4 w-as significantly greater than that in groups 1
and 2*.
Latent Ieriodl
The average timne before tle first tumnour wN-as detected in groups 3 and 4 was
slightly slhorter thalni the combinied (refer Tumiour Incidenice) average observed in
groups 1 and 2 (Table 1). Statistically. thie average of I113 days (groups 1 and 2)
dlid Inot differ signiificanitly from the average for gropl) .3, but wras signiificantly
greater than the average for grou) 4. The average latenit period for group 3 did
not differ significantly from tlhat, ofgroup 4. but ifthese two groups are pooled, the
weiighted average of 85 days is signlificantly less tlhan the pooled average from groups
1 and 2*. This is illustrated in Fig. 1. whliere it can be seen that 5800X and 570/ of
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FiT;. 1.-Histogram sho-inig inereased tumiour incidence ani shorteniing of induction tlime n
groups 3 and1 4 followinig progesterone adminiistr-ation in adidltloni to DflMBA, compared1 \x ith
that for groups 1 aone 2 which received DMBA only. Percentages in groups 1 and 2 4 aere
based on 42 rats, anid in groups 3 anttI 4 on il) and 14 ani-mals, respectivel'y.
tumours in groups 3 anid 4, respectively, wNere first detected between 40 anid SO
days after IDMlA adminiistration, wh-Iile in this same period only 1200 of mammary
gyrowvNths developed in rats ofgroups 1 anid 2, the majority in these latter two groups
first occurring between- 120 and 160 days after applicationi of the carcinogen.
Tumiour mnultiplicity
M,\ore thian- one mammary grow\Nth arose in maniy aniimals in groups 1-4, and
administration of progesterone appeared to enhance considerably multi-tumour
development regardless of whether the hormone implantations were begun before
or after the first neoplasm lhad appeared (Table I).
* Details of the statistical analyses made lin each section have been omitted, but H. Scheffes
miethod (Bionictrika, 1953, 40, 87-104) Nas used wxhenever multiple comparisons were made wxithin a
set of results.ANNE G. JABARA
With the exception of the comparisons between groups 3 and 4, x2 tests were
made against a one-sided alternative that progesterone enhanced multi-tumour
development, and were based only on rats which had developed at least one
tumour*. These showed that progesterone significantly increased the probability
of tumour multiplicity, but that the incidence ofmultiple tumours induced in rats
of groups 2-4 did not differ significantly amongst themselves.
Active centres
The total number of multiple tumours (active centres) developing in any rat
differed from animal to animal even within the same group. However, pro-
gesterone, regardless of the time of its administration, appeared to increase the
average number ofactive centres per rat in groups 2-4 compared with the average
number per rat in the control group 1 (Table I), and this difference was found to be
statistically significant.
The statistical analysis of the four treatments (groups 1-4) was based on the
results observed in all rats, including animals with no tumours and those with only
one neoplasm (Table II). The same one-sided alternative was used for all com-
parisons (refer Tumour Multiplicity), except for that between groups 3 and 4.
Theanalysis* showedthatthenumber ofactive centres developingineither group 1
or group 2 was significantly lower than that in group 3, but was not significantly
lower than the number in group 4, and that DMBA alone (group 1) induced sig-
nificantly fewer active centres than the weighted average of the active centres in
groups 2-4. Statistical analysis ofthe differences between the three progesterone-
treated groups (2-4) revealed that while the differences in the number of active
centres between groups 2 and 4 and 3 and 4 were not significant, progesterone
given 15 days after DMBA administration (group 3) significantly increased the
number of active centres as compared with group 2.
* See footnote page 421.
EXPLANATION OF PLATES
FIG. 2. Portion of a solid type of carcinoma, showing actively proliferating epithelial cells
arranged in dense cellular sheets; many of these cells contain mucin or fat vacuoles in their
cytoplasm. H. & E. x 100.
FIG. 3.-Portion of a solid type of carcinoma, showing accumulation of mucin intercellularly
(bottom), and the presence of several small glandular structures, some of which appear to
have invaded a fibrous septum. H. & E. x 100.
FIG. 4. Portion of a papillary cystadenocarcinoma, showing two cystic spaces separated by
fibrous trabeculae and each almost entirely filled by proliferating epithelial cells which are
arranged in a papillary pattern. H. & E. x 40.
FIG. 5.-Portion of a cystic space in a papillary cystadenocarcinoma, showing the presence of
glandular structures and relatively scanty and fibrillary stroma within papillae. H. & E.
x 100.
FIG. 6.-Papillae within a cystic space of a papillary cystadenocarcinoma, showing considerable
mucinous cytoplasmic vacuolation in many of the epithelial cells, accumulation of mucin
intercellularly, and the presence of several glandular structures. Alcian blue. x 100.
FIG. 7.-Portion of an adenoma, showing the nodular arrangement of numerous ductal and
acinar structures, each nodule being bounded by narrow fibrous septa. H. & E. x 40.
FIG. 8. Portion of an adenoma, showing the presence of numerous ducts and acini within a
nodule, the acini containing fat droplets and eosinophilic material in their lumina, and
cytoplasmic fat vacuoles in many of the epithelial cells lining both types of adenomatous
structures. H. & E. x 100.
FIG. 9.-Portion of a fibroadenoma, showing numerous small solid or luminated ducts sur-
rounded by abundant dense fibrous stroma. H. & E. x 40.
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Growth behaviour of tumours
Three main types of tumour growth behaviour occurred in all four groups of
animals (Table III). Many neoplasms grew continuously, either rapidly or
TABLE III.-Growth Behaviour ofInduced Mammary Tumours
Total No.
of rats Percentage of tumours
Group with Total No. , x_
No. tumours of tumours CG S R Unclassified
1 . 8 . 11 .46 27 27 0
2 . 10 . 39 .56 26 8 10
3 . 16 . 71 .42 30 20 8
4 . 9 . 29 .31 38 21 10
CG = Continuous growth.
S = Static growth.
R = Regressing.
gradually, until they were either removed surgically or the host was killed at the
end of the experiment. This was designated " continuous growth ". Other
tumours, following an initial short growth period, remained about the same size
for the remainder of the experiment, and this type of growth was classified as
" static ". Still other neoplasms initially showed a short period of growth and
then gradually diminished in size until they either completely disappeared or
were considerably smaller than 1 cm. in longest diameter. This type of progress
was classified as " regressing ". Some tumours in all four groups showed a more
complicated growth behaviour, involving combinations of any two of the three
main types, and neoplasms exhibiting such combinations were for simpllcity
classified on their initial growth progress (Table Ill). The growth behaviour for
a small percentage oftumours arising in groups 2-4 (Table III) could not be classi-
fied because most ofthese neoplasms arose late in the experiment and were either
too small to be measured orhad not been measuredfor a sufficient length oftime to
determine their true growth pattern before the hosts were killed. A few growths
were undetected until the host was autopsied. Progesterone did not appear to
influence tumour growth behaviour (Table III). This was confirmed statistically,
when an overall test of independence of treatments and growth behaviour of
tumours was not found to be significant, nor was there any marked deviation in
any single observed result from that which would be expected ifthe hypothesis of
independence were correct.
Microscopic examination of the neoplasms revealed no direct correlation
between growth behaviour and histological picture, and a carcinoma, fibroa-
denoma or adenoma might all show continuous growth, or might remain static.
However, while the majority of carcinomata and adenomata exhibited continuous
growth, the majority offibroadenomata remained static.
Locations of tumours
In all four groups there was no apparent predilection for tumours to develop
on one side rather than the other, both sides being equally affected. The majority
ofgrowths in all groups arose in the first three pairs ofglands, and less frequently
the 4th, 5th and 6th pairs ofglands were affected in descending order offrequency.
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Types of tumours
Three main tumour types were distinguished (Table IV), and all of these
occurred in each of the four groups of rats (1-4), progesterone appearing not to
influence either the macroscopic or microscopic appearances of the developing
growths.
TABLE IV.-Percentage of Histoloyically Similar Tumour Types in Each Group
Percentage
Total No. , __
Group of Fibro- Unclassi-
No. tumours Carcinoma Adenoma adenoma fiable*
1 . 11 73 0 9 18
2 . 39 79 8 5 8
3 . 71 . 56 20 12 12
4 . 29 . 66 14 17 3
* Tumours were unclassifiable due to complete regression before autopsy or because they were lost
during paraffin embedding.
(a) Carcinoma.-The majority of neoplasms in all four groups were of this
type (Table IV). Macroscopically they appeared as ovoid, partially encapsulated
growths of soft to firm consistency, which weighed up to 70 g. and measured up
to 6-0 x 5'5 cm. The cut surfaces revealed pink, white or cream-coloured
nodular tissue whichwas sometimes solid, but more frequently contained multiple
cysts, ranging from 1-7 mm. in diameter and filled with dark brown-coloured
semi-gelatinous material; the tumours sometimes contained a necrotic focus
centrally.
Microscopically carcinomata were either of a solid and poorly differentiated
type, or else, and this involved the majority of growths, well-differentiated papil-
lary cystadenocarcinomata. Most carcinomata showed both patterns and were
classified on their predominant feature. The poorly differentiated type consisted
predominantly of solid sheets, clumps and cords of actively proliferating, pleo-
morphic, hyperchromatic epithelial cells (Fig. 2), although small, or sometimes
cystic, adenomatous formations of acinar or ductal type were often seen (Fig. 3).
The papillary cystadenocarcinomata, on the other hand, were composed pre-
dominantly of large cystic spaces which were completely or partially filled by
proliferating epithelial cells which were generally arranged in a papillary pattern
(Fig. 4); mitotic figures were less frequent than in the solid type. Within these
papillae the intercellular stroma was scanty and fibrillary, but ductal and acinar
structures were common (Fig. 5).
In both types of carcinomata the epithelial cells frequently contained cyto-
plasmic mucinous vacuoles (alcian blue positive) or, less commonly, fat vacuoles
(Sudan III positive) (Fig. 2 and 6); intercellular pools of mucin were also seen
(Fig. 3 and 6). The stroma in both tumour types was generally relatively sparse
and commonly infiltrated by large and small mononuclear cells, eosinophils and
mast cells. Small or larger necrotic foci were sometimes observed, especially near
the tumour centre. Myoepithelial cells were observed scattered around many of
the glandular structures and also mixed with epithelial cells within the cellular
sheets and clumps. Metastases were not found in any case.
(b) Adenoma.-This type of tumour was considerably less frequent than
carcinoma, but appeared with approximately the same incidence as fibroadenoma
(Table IV). Macroscopically they appeared as ovoid, encapsulated masses ofsoft
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consistency, weighing up to 36 g. and measuring up to 5 0 x 4 0 cm. In cross
section, they were composed of cream-coloured nodules which contained multiple
small cysts, ranging from less than 1-7 mm. in diameter and filled with dark
brown-coloured semi-gelatinous material.
Histologically, adenomata consisted ofnumerous glandular structures arranged
in a nodular pattern, each nodule being bounded by relatively narrow fibrous septa
which contained small and large mononoclear cells, eosinophils and mast cells
scattered through them (Fig. 7). Commonly the adenomatous formations con-
sisted exclusively or predominantly of small ducts, although many tumours, in
addition, contained small or cystic acinar structures. Most of the epithelial cells
contained cytoplasmic fat vacuoles (Fig. 8), and mitotic figures were infrequent.
In most ducts and acini myoepithelial cells were visible lying just within the base-
ment membranes.
(c) Fibroadenoma.-Macroscopically these tumours appeared as encapsulated,
ovoidordiscoid massesofrubbery consistency, whichmeasuredupto 20 x 1-5 cm.
and weighed up to 3 g. The cut surfaces revealed small buff-coloured or greyish-
cream-coloured nodules scattered in dense white tissue.
Histologically fibroadenomata consisted of dense fibrous tissue in which were
situated small solid or luminated ducts (Fig. 9) and, less frequently, small acinar
formations. Both acinar and ductal epithelial cells often contained cytoplasmic
fat vacuoles, and mitotic figures were rare. Myoepithelial cells could sometimes
be distinguished in the lining ofducts and acini.
DISCUSSION
The observation that progesterone per se did not induce mammary neoplasia
in any rat of group 5 confirms the findings of Gruenstein et al. (1964), Huggins
et al. (1959) and Poel (1965), who administered this hormone, respectively, to
Wistar and Sprague-Dawley rats and to mice.
The reported incidences and induction times of mammary tumours and the
average number of active centres developed per animal following the feeding of a
single dose ofDMBA to Sprague-Dawley rats have varied considerably, even when
a dose ofcomparable size was administered (Table V). Comparison ofthe findings
TABLE V.-Reported Results ofFeeding DMBA to Sprague-Dawley Rats
Single Average
intra- Range of No. of
gastric Percentage tumour active
dose tumour induction centres
Investigators (mg.) incidence time (days) per rat
Huggins et al. (1961) . 20 . 100 . 28-60 . 6-8
Huggins and Yang (1962). . 20 . 100 . 21-60 . 2-1
28-39* 5.0*
Huggins et al. (1962). 20 100 . 27-72 . 2.7
24-49* . 3.6*
Sydnor et al. (1962) . . 20 . 100 25-54 3*8
Talwalker et al. (1964) . . 20 . 100 . 52-110 . 3.9
McCormick and Moon (1965) . 20 . 100 46-137 . 4 95
24-39t . 3 07t
Teller et al. (1966) . . 20 70-6 . 91-218 . 5-1
Young and Cowan (1963) . 50 . 62 . 50-100
Young et al. (1963) . . 50 . 57
* Results following progesterone administration from day 15 to day 45 after feeding DMBA.
t Results following induction of pregnancy from day 16 to day 29 after feeding DMBA.
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in the control animals (group 1) with previously reported observations revealed
that the mammary tumour incidence was slightly lower, while the range of
induction time and the average number of active tumour centres per rat were both
comparable with those recorded by several investigators (Table V). It appears
possible that the results obtained may depend upon the substrain of Sprague-
Dawley rat used.
Progesterone significantly increased the tumour incidence in the present
series, and further, it did so regardless of whether it were given just before, or 15
days after, DMBA application. Huggins and his colleagues and McCormick and
Moon, however, obtained a 100% tumour incidence whether or not progesterone
was administered, or pregnancy induced, in addition to DMBA (Table V).
The significant decrease in tumour induction time observed in rats of group 3,
which received progesterone continuously beginning 15 days after DMBA admini-
stration, confirms the observations ofHuggins and co-workers (Table V). Further
it was found that progesterone given two days before DMBA was just as effective
in shortening the latent period. McCormick and Moon (1965) found that preg-
nancy induced 16-29 days after DMBA administration had a similar shortening
effect on tumour induction time (Table V).
The increases in tumour multiplicity and the number of active centres per rat
following progesterone administration 15 days after DMBA confirms the findings
of Huggins and co-workers (Table V). However, McCormick and Moon (1965)
found that pregnancy occurring 16-29 days after DMBA administration did not
increase the number of tumours per rat (Table V), although further new growths
arose resulting in an increase in the number of active centres per animal when the
rats were mated after the first neoplasms had developed. A similar finding was ob-
tained in group 2 of the present series following the implantation of progesterone
in tumour-bearing rats. Further, it was found that when progesterone was given
before DMBA there was a significant increase in the number of tumour centres
developed. Thus, the average number of active centres per rat was increased in
all groups receiving progesterone regardless ofwhen the hormone was administered,
but the greatest increase in number was observed in rats which received proges-
terone 15 days after DMBA. However, there was a high casualty rate in group 4
early in the experiment, and therefore the results in this group may not describe
accurately the influence of progesterone when given before DMBA.
The observed variation in growth behaviour of DMBA-induced mammary
tumours even in the same group of animals, or in the same rat, confirms the work
of Young, Cowan and Sutherland (1963), Young and Cowan (1963) and Teller
et al. (1966), and further, progesterone did not appear to influence these neoplastic
growth patterns. However, Huggins et al. (1962) and Huggins and Yang (1962)
reported that progesterone significantly enhanced the growth rate of DMBA-
induced mammary tumours, and similarly McCormick and Moon (1965) observed
that the tumours grew more rapidly during pregnancy, regardless of whether the
rats were mated before or after mammary neoplasms had appeared.
In the present series, administration of progesterone in addition to DMBA did
not modify the locations or the macroscopic or microscopic appearances of the
induced tumours, regardless of when the hormone was implanted. It has been
suggested that the hormonal conditions prevailing in an animal at the time when a
carcinogen is exerting its effect determine the type of tumour which develops (Shay,
Harris and Gruenstein, 1952; Daniel and Prichard, 1964). However, this does not
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appear to be the complete answer in view of the fact that similar histological
tumour types were observed in all four groups of rats of the present experiments,
despite the different hormonal conditions which existed in each group. The ab-
sence of adenomata from group 1 (Table IV) was not considered to be significant
as so few tumours developed in this group within the duration of the experiment
(61 months). This tentative conclusion was subsequently proved correct when
this group ofrats was kept alive for a further 21 months after the conclusion ofthe
main experiment. By the end of 9 months the number of rats in this group
bearing tumours had increased from 8 to 17, and the number of mammary neo-
plasms had increased from 11 to 56, ofwhich 13 (23%) were adenomata.
While myoepithelial cells were invariably present in the growths, they appeared
to make little contribution to the tumours, and in all growths ofthe present series,
the epithelial cell was the predominant cell type, regardless ofwhether the growths
were benign or malignant and whether or not progesterone had also been admini-
stered.
Thus, while progesterone per se was not carcinogenic in the Sprague-Dawley
rat, it was found that the hormone significantly enhanced mammary tumorgenesis
induced by DMBA, regardless of whether the steroid was administered 2 days
before feeding the carcinogen, or 15 days after DMBA application (confirming the
findings ofHuggins et al., 1962), or after the first mammary growths had appeared.
From this last observation, it was concluded that exogenous progesterone was as
effective in enhancing DMBA-induced tumorgenesis, as McCormick and Moon
(1965) found the induction of pregnancy to be in tumour-bearing rats.
The mechanism by which progesterone enhances the tumorgenic response is
not yet known. However, the work of several authors suggests that the anterior
pituitary hormones, prolactin and somatotrophin (STH), maybe of prime impor-
tance in the induction of mammary growths in rats by DMBA or 3MCA (Young,
1961; Sterental et al., 1963; Talwalker, Meites and Mizuno, 1964), and there is
some evidence to suggest that progesterone may act indirectly via the pituitary
gland and hypothalamus inducing an increased secretion ofprolactin and possibly
STH as well (Rothchild, 1960; Huggins, Mainzer and Briziarelli, 1958). Bock and
Dao (1961) have postulated that the end effects of hormones upon tumour forma-
tion may be due primarily to an alteration of the target cells, rather than to
changes in the amount of carcinogen to which they are exposed. The findings in
group 2 ofthe present series appear to support this view, progesterone apparently
enhancing the appearance ofmany tumours which might otherwise have remained
dormant. Bock and Dao (1961) suggested that the alteration possibly may
effect either the absorption of DMBA by the mammary epithelial cells from the
storage depot of carcinogen in the mammary adipose tissue, or the metabolism of
DMBA within the cells. The former suggestion is currently being investigated in
this laboratory by means of tritiated DMBA and autoradiography.
SUMMARY
One hundred and five non-inbred Sprague-Dawley virgin female rats were
divided into 5 groups. Rats in groups 1-4 were given a single intragastric dose
of 30 mg. of DMBA at 50 days of age. Group 1 received no other treatment.
Groups 2, 3 and 4 received in addition a 200 mg. i.p. implant of progesterone every
30 days. The time of administration of the first dose of progesterone differed in
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each group: in group 2 it was given after the appearance of the first mammary
tumour, in group 3, 15 days after DMBA administration and in group 4, two days
before the dose ofDMBA. Animals in group 5 received progesterone only in the
same dosage, the first implant being given at 48 days of age. The experiments
were continued for 6i months.
Mammary tumours developed in groups 1-4, but none arose in any animal in
group 5. Progesterone significantly increased the incidence of mammary neo-
plasms and reduced the time for tumour induction in groups 3 and 4, administra-
tion ofthe hormone just before DMBA application being as effective in this regard
as when it was given 15 days after DMBA. Progesterone also significantly
enhanced the development of multiple tumours and increased the number of
neoplasms per rat, regardless of whether the hormone implantations were begun
before or after tumour appearance. The increase in the number of active tumour
centres per rat was greatest when progesterone was administered 15 days after
DMBA (group 3), but as a relatively high casualty rate cocurred in group 4 early
in the experiment the results in this group may not describe accurately the
influence ofprogesterone administration starting two days before DMBA.
Progesterone did not appear to influence the side or site ofneoplastic develop-
ment, nor the growth behaviour or macroscopic and microscopic appearances of
the tumours.
This work was carried out during the tenure of a Research Training Grant
from the World Health Organization, Geneva.
The author wishes to thank Professor E. Cotchin, Department of Pathology,
Royal Veterinary College, London, for his support and encouragement and the
many helpful discussions during the course of these experiments, and Miss A.
Doig, Department of Statistics, University of Melbourne, for carrying out the
statistical analysis of the data.
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